Bernal PM, Bezerra SDL, Gómez BFJ, Gómez BGJ

Language: Spanish
References: 28
Page: 23-29
PDF size: 290.23 Kb.

ABSTRACT

Incidence rates and mortality from cutaneous melanoma increased significantly in recent years around the world representing average rates in Spain. Material and methods: As a source of data has been used mortality statistics from the National Institute of Statistics. The method used has been MIAMOD. Results: Only increases were observed in mortality from cutaneous melanoma in women. Both incidence rates in women as incidence rates and mortality in men were showed no statistically significant variations. Conclusions: It is necessary to maintain the primary and secondary prevention for this disease because it is expected to have increases in mortality in men.

REFERENCES

1. Melanoma skin cancer Males. Cancer Incidence in Five Continents IX http://ci5.iarc.fr/CI5plus/table2.asp.

2. Epi base. Centro Nacional de Epidemiología. http://cne.isciii.es/

3. Instituto Nacional de Estadística (INE). http// www.ine.es.

4. De Angelis G, de Angelis R, Frova L, Verdecchia A. MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Programs Biomed. 1994; 44: 99-107.

5. Weibull, W. A statistical distribution function of wide applicability. J Appl Mech-Trans ASME. 1951; 18: 293-7.

6. Eurocare 4. http:// www.istitutotumori.mi.it

7. INE.http://www.ine.es/jaxi/tabla.do?path=/t15/p417/a2009/l0/&file=02003.px&type=pcaxis&L=0.

8. Joinpoint program. http://srab.cancer.gov/joinpoint/

9. Nasser N. UVB: susceptibility in malignant melanoma. An Bras Dermatol. 2010; 85: 843-8.

10. Shibata T, Kokubu A, Miyamoto M, Sasajima Y, Yamazaki N. Mutant IDH1 Confers an in vivo Growth in a Melanoma Cell Line with BRAF Mutation. Am J Pathol. 2011; 178: 1395-402.

11. Nordpred. A software for predicting trends in cancer incidence,

12. Dyba T, Hakulinen T. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med. 2000; 19: 1741–52.

13. WHO Disponible en: http://www-dep.iarc.fr/WHOdb/table3.asp.

14. Curado, MP, Edwards B, Shin HR. Cancer in Five Incidence: http://ci5.iarc.fr/ 2009 IARC Scientific Publication, No 160 Lyon Franc.

15. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borràs J, Clèries R et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010; 24: 1083-8.

16. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004; 40: 2355-66.

17. Stang A, Jöckel KH. Declining mortality rates for non melanoma skin cancers in West Germany, 1968-99. Br J Dermatol. 2004; 150: 517-22.

18. Olsen AH, Parkin DM, Sasieni P. Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer. 2008; 99: 1549-54.

19. Registro de cáncer de España. Incidencia y mortalidad por cáncer 2001-2005. Gobierno de España 2011 http://saludpublicaEspaña.es.

20. SEER. http://seer.cancer.gov/statfacts/html/breast.html.

21. http://www-dep.iarc.fr/WHOdb/table1.asp.

22. Pollan M, López-Abente G. Mortality trends in cutaneous malignant melanoma in Spain 1967-1986. Cancer Epidemiol Biomarkers Prev. 1993; 2: 545-50.

23. http://seer.cancer.gov/statfacts/html/melan.html#incidence-mortality.

24. Giblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthet Surg. 2007; 60:32-40.

25. Makredes M, Hui SK, Kimball AB. Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting. Melanoma Res. 2010; 20: 427-30.

26. http://seer.cancer.gov/statfacts/html/melan.html.

27. Diffey BL. The future incidence of cutaneous melanoma within UK. Br J Dermatol. 2004; 151: 868-72.

28. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007; 57: 555-72.